natgillin/translations-raw huggingface dataset:
The composition according to any of the preceding claims, wherein the one or more additional active agent is selected from the group consisting of an arylpyrazole, a neonicotinoid, a pyrethroid, an amino acetonitrile compound, a paraherquamide, a spinosyn active, a cyclic depsipeptide, a benzimidazole active, an imidazothiazole active, a tetrahydropyrimidine active, praziquantel, an avermectin, a milbemycin and an insect growth regulator. 
Veterinarski ili agrikulturni sastav prema zahtjevu 24, naznačen time, da je antitrematodno sredstvo odabrano iz skupine koja se sastoji od sljedećih: miracil D, mirasan, prazikvantel, klonazepam, meklonazepam, oltipraz, lukanton, hikanton, oksamnikin, amoskanat, niridazol, nitroksibil, heksaklorofen, bitionol, bitionol-sulfoksid, meniklofolan, tribromsalan, oksiklonazid, klioksanid, rafoksanid, brotianid, bromoksanid, klozantel, triklabendazol, diamfenetid, klorsulon, hetolin i emetin.
A therapeutic antibody according to claim 5 in which residues 235 and 237 have been mutated to alanine 
Terapijsko protutijelo u skladu s patentnim zahtjevom 5, naznačeno time što su ostaci 235 i 237 imitirani u alanin.
The membrane element 222 is then applied in the mold and the breathable element 221 is positioned. 
Zatim se membranski element 222 umeće u kalup i postavlja prozračni element 221.
The veterinary or agricultural composition according to claims 1-17, wherein the additional active agent is a spinosyn or a substituted pyridylmethyl derivative. 
Veterinarski ili agrikulturni sastav prema zahtjevima od 1 do 17, naznačen time, da dodatna djelatna tvar je spinozin ili supstituirani derivat piridilmetila.
The hand piece of claim 5 further comprising: a moveable member that engages disposable segment, a position of the moveable member with respect to the disposable segment determining a leakage that decreases vacuum pressure in the rigid length of aspiration line. 
Ručni aparat prema zahtjevu 5, naznačen time, da se položaj osovine (220) može podešavati u odnosu na raspoloživi odjeljak (230), u svrhu određivanja curenja koje smanjuje tlak vakuuma u krutoj duljini usisnog voda.
A method for the preparation of a compound of formula I or a salt thereof comprising reacting a compound of formula VIa (i.e. Compound VI for which LG is Cl) with 2,2-dimethylpiperazine in presence of a base, followed by reductive amination with suitably reagents, such as formaldehyde, paraformaldehyde, trioxane or diethoxymethane followed by isolation of the compound of formula I as the free base or as a salt thereof. 
Postupak pripreme spoja formule I ili njegove soli koji obuhvaća reakciju spoja formule Vla (tj. Spoja VI kojemu je odlazna skupina C1) (Vla) s 2,2-dimetilpiperazinom u prisutnosti baze, nakon čega slijedi reduktivna aminacija pomoću prikladnih reagensa kao npr. formaldehid, paraformaldehid, trioksan ili dietoksimetan nakon čega slijedi izolacija spoja formule I kao slobodne baze ili njegove soli.
The method of claim 38, wherein the cancer is selected from breast, brain, cervix, colon, head & neck, liver, kidney, lung, non-small cell lung, melanoma, mesothelioma, ovary, sarcoma, stomach, or uterus. The method of claim 38, wherein the cancer is selected from Medulloblastoma, Hodgkin's Disease, Non-Hodgkin's Lymphoma, multiple myeloma, neuroblastoma, rhabdomyosarcoma, primary thrombocytosis, primary macroglobulinemia, a primary brain tumor, malignant pancreatic insulanoma, malignant carcinoid, urinary bladder cancer, testicular cancer, lymphomas, thyroid cancer, esophageal cancer, genitourinary tract cancer, malignant hypercalcemia, endometrial cancer, adrenal cortical cancer, neoplasms of the endocrine and exocrine pancreas, and prostate cancer. 
Varijanta HSV ili farmaceutska formulacija za uporabu prema zahtjevu 32, naznačena time što je karcinom odabran iz skupine koja sadrži rak dojke, mozga, grlića maternice, debelog crijeva, glave i vrata, jetre, bubrega, pluća, rak pluća ne-malih stanica, melanom, mezoteliom, rak jajnika, sarkom, rak želuca, rak maternice i meduloblastom, Hodgkinovu bolest, ne-Hodgkinov limfom, multipli mijelom, neuroblastom, rak jajnika, rabdomiosarkom, primarnu trombocitozu, primarnu makroglobulinemiju, primarne tumore mozga, maligni inzulinom gušterače, maligni karcinoid, rak mokraćnog mjehura, premaligne lezije kože, rak testisa, limfome, rak štitnjače, neuroblastom, rak jednjaka, rak genitourinarnog trakta, malignu hiperkalcemiju, rak endometrija, karcinom nadbubrežne žlijezde, neoplazme egzokrinog i endokrinog tkiva gušterače, i rak prostate.
The floor panel of claim 15, wherein said locking element consists of a synthetic material strip. 
Podni panel prema patentnom zahtjevu 9 ili 10, naznačen time što se zasebni umetak sastoji od okretnog elementa za blokiranje.
The process of claim 11 further comprising coupling an amino-terminal protected Asp residue having a protected carboxyl side chain to a Trp-Pro dipeptide through the Trp residue of the dipeptide and removing the amino-terminal protecting group from the Asp residue to form the 4-6 eptifibatide fragment. 
Produkt prema patentnom zahtjevu 10, naznačen time da navedeni postupak nadalje sadrži vezanje zaštićenog amino-terminalnog rezidua Asp koji ima zaštićeni karboksilni bočni lanac na Trp-Pro dipeptid putem rezidua Trp dipeptida i uklanjanje zaštitne amino- terminalne skupine iz rezidua Asp kako bi se formirao fragment 4-6 eptifibatida.
A seating apparatus obtainable by the method according to one or more of the claims 1 to 27. 
. Uređaj sjedišta, naznačen time što se može dobiti pomoću postupka prema jednom ili više patentnih zahtjeva 1 do
Below this upper shoulder the gap will start. 
Raspor će početi ispod ovog gornjeg izbočenja.
a mutated OmpT gene, wherein the mutated OmpT gene encodes a OmpT protein having reduced protease activity or is a knockout mutated OmpT gene. 
mutirani OmpT gen, naznačen time, što mutirani OmpT gen kodira OmpT protein sa smanjenom aktivnosti proteaze ili pak predstavlja isključeni mutirani OmpT gen.
The shaped article according to any one of claims 1 to 8, wherein the tapered recesses have a V shape or a deformed V shape, the deformed V shape having preferably at least one of the following features: curved side walls, and 
Oblikovani članak (100) prema bilo kojem od patentnih zahtjeva 1 do 8, pri čemu konusna udubljenja (40) imaju oblik V ili deformirani oblik V, poželjno je da deformirani oblik V ima najmanje jedno od sljedećih obilježja:
for use in a method for treating muscle cramps, musculoskeletal irritability, or for improving muscle recovery in a subject in need thereof, wherein said composition is an oral formulation that is a liquid, beverage, gel, solid, semi-solid, chewing gum, or spray, wherein said composition comprises a TRPV1 channel activator wherein said TRPV1 channel activator is capsaicin or another capsaicinoid preferably wherein said TRP channel activators are independently selected from capsicum; 
(c) gingerola, za upotrebu u postupku liječenja mišićnih grčeva, mišićno-skeletne nadraženosti, ili za poboljšanje oporavka mišića kod subjekta kojem je to potrebno, pri čemu je navedeni pripravak oralna formulacija koja je tekućina, napitak, gel, čvrsta tvar, polukruta tvar, guma za žvakanje, ili sprej, pri čemu navedeni pripravak sadrži aktivator TRPV1 kanala pri čemu je navedeni aktivator TRPVI kanala kapsaicin ili drugi kapsaicinoid poželjno pri čemu su navedeni aktivatori TRP kanala neovisno odabrani od
represents a side chain of an amino acid residue selected from Asn, Asp, Gln, and Glu; and Aaa is an amino acid residue selected from Thr and Ser; wherein the C-terminus thereof is a free terminus, is amidated, or is esterified. 
R3 predstavlja pobočni lanac aminokiselinskog ostatka kojeg se bira između Asn, Asp, Gin, te Glu; i Aaa je aminokiselinski ostatak, kojeg se bira između Thr i Ser; gdje je C-kraj njegov slobodni kraj, amidiran ili esterificiran. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je Aaa aminokiselinski ostatak, kojeg se bira između Thr i Ser; gdje je C-kraj slobodni kraj.
A pharmaceutical combination comprising 
Farmaceutska kombinacija naznačena time da sadrži
decreasing the total amount of soluble AB in the brain of an animal, particularly a mammal, but especially a human suffering from a disease or condition leading to increased concentrations of soluble AB in the brain; 
smanjenju ukupne količine otopinskog AB u mozgu neke životinje, posebno sisavaca, ali naročito humanog bića koje pati od bolesti ili bolesnog stanja asociranih sa amiloidom; ili
Preferably, the acid has a pKa at 25° C. of 2.5 or less. If the pKa at 25° C. is 0 or less, the acid is preferably selected from sulphuric acid, hydrochloric acid, or mixtures thereof. 
Postupak prema jednom od prethodnih zahtjeva, pri čemu kiselina ima pK, pri 25C 2.5 ili manje, poželjno pK, pri 25*C od 0 1li manje, te je poželjno sumporna kiselina, klorovodična kiselina, ili njihova smjesa.
The detection device of claim 1, wherein said antigen or antigenic peptide is from an organism selected from the group consisting of heartworm, Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia ewingii, Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, Anaplasma phagocytophilum, Anaplasma platys, feline leukemia virus, parvovirus, influenza A strain, influenza B strain, avian influenza virus, respiratory syncytial virus, Legionella, adenovirus, rotavirus, feline immunodeficiency virus, human immunodeficiency virus, and Group A Streptococcus. 
Postupak u skladu s patentnim zahtjevom 1, naznačen time što navedeni antigen ili antigeni peptid izt drugog detektora je iz organizma kojeg se bira iz skupine koju čine srčana glista, Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia_ewingii, Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, Anaplazma phagocytophilum, Anaplazma platys, virus mačje leukemije, parvovirus, soj A influence, soj B influence, virus ptičje influence, respiratorni sincicijski virus, Legionella, adenovirus, rotavirus, virus mačje imunodeficijencije, virus ljudske imunodeficijencije, te skupina A streptokoka.
a disease relapse, optionally wherein said disease relapse occurs after treatment with an E . coli L-asparaginase or PEGylated form thereof. 
povrat bolesti, proizvoljno pri čemu se navedeni povrat bolesti javlja nakon liječenja s L-asparaginazom E.coli ili njezinim PEG-iliranim oblikom.
As soon as the above-cited spout 220 is formed in this manner, the power supply to the solenoid 182 is cut off, and the solenoid itself is de-energized, so that the reaction force of the counter-spring prevails over the overall weight of the plunger 181, the rod 183 and the roller 184 and, as a result, the lever 114, by pivoting back in the reverse direction, is able to move from this operating configuration back to its previously described resting configuration. 
Čim tako nastane gore navedeni mlaz 220, napajanje zavojnice 182 se prekida, gdje zavojnica ostaje bez napona, tako da sila reakcije protuopruge savladava ukupnu težinu klipa 181, klipnjače 183 i valjka 184, te se zbog toga poluga 114, zakretanjem natrag u povratnom smjeru, može vratiti iz te radne konfiguracija u svoju prethodno opisanu konfiguraciju mirovanja.
is optionally substituted C5-C10 alkyl, wherein said optional substituents arc one to three R10 groups; 
R* je proizvoljno supstituiran Cs-C;g alkil, pri čemu su navedeni nezavisni supstituenti jedna do tri R'" skupine;
is selected from the group consisting of hydrogen, methyl, chloro, fluoro, hydroxy, methoxy, ethoxy, propoxy, carbamoyl, dimethylamino, amino, formamido, and trifluoromethyl; and X is selected from the group consisting of CO and SO2. In a further aspect of the invention, suitable identities for R1 include, but are not limited to, unsubstituted imidazolyl and substituted imidazolyl. Suitable substitutions for the substituted imidazolyl group include, but are not limited to, C1-C6 alkyl. 
R, je odabran iz skupine koju čine: vodik, C;-Cg alkil, C3-Cgcikloalkii, aril, supstituirani aril, heteroaril i supstituirani heteroaril, gdje su aril, heteroaril i supstituenti za aril i heteroaril prethodno definirani; R, je odabran iz skupine koju čine: halogen, C;-Cgalkil, C3-Cg cikloalkii, cijano, nitro, CF, karbamoil, C,-Cgalkilkarbamoil, amino, C,-Cgalkilamino, C,-Cgdialkilamino, C,-Cgalkoksi i C3-Cgcikloalkoksil;
The method of any of Embodiments 1 through 4, wherein the refrigerant exhibits a boiling point below about −35° C. 
Postupak prema Zahtjevu 1, gdje rashladno sredstvo pokazuje točku vrenja ispod oko -35"C.
The method according to claim 18 wherein the chromatography is selected from the group consisting of Hydrophobic Interaction Chromatography (HIC), Ion Exchange chromatography (IEC), Size exclusion chromatography (SEC), Affinity chromatography, and Reversed-phase chromatography, optionally wherein an anti-chaotropic salt is used in a chromatography loading step and in a chromatography washing step; optionally wherein the chromatography takes place in a column, such as a column comprising a chromatography resin selected from the group consisting of Phenyl-Sepharose FF and Butyl-Sepharose FF; and wherein the resin is preferably present in the column at a bed height of between about 5 cm and about 20 cm, preferably about 10 cm. 
Postupak prema zahtjevu 18, pri čemu je kromatografija odabrana od skupine koja se sastoji od kromatografije hidrofobnih interakcija (HIC), ionoizmjenjivačke kromatografije (IEC), kromatografije isključenjem po veličini so HR P20190990 T1 (SEC), afinitetne kromatografije i kromatografije reverzne faze, izborno pri čemu je anti-kaotropska sol korištena u koraku punjenja kromatografije i koraku ispiranja kromatografije; izborno pri čemu se kromatografija događa u koloni, kao što je kolona koja sadrži kromatografsku smolu odabranu od skupine koja se sastoji od Fenil-Sefaroze FF i Butil-Sefaroze FF; i pri čemu je smola poželjno prisutna u koloni visine sloja od između oko 5 em i oko 20 cm, poželjno oko 10 cm.
Bathroom facility according to claim 6, characterised in that it comprises control means (23, 24) for supplying water to the bidet and wc bowls, the control means being arranged at the upper wall (13) of the bathroom facility between the two bowls (14, 15). 
Kupaonska oprema sukladno zahtjevu 6, naznačena time što sadrži kontrolna sredstva (23, 24) za dovod vode do bide i wc školjke, kontrolna sredstva organizirana su na gornjem zidu (13) kupaonske opreme između dviju školjki (14, 15).
and R2, together with an atom linked thereto, form 3- to 10-membered heterocyclyl or 5- to 10-membered heteroaryl, wherein the heterocyclyl or heteroaryl is optionally substituted by halogen; 
i R2, zajedno s atomom vezanim za njih, formiraju 3- do 10-eročlani heterociklil ili 5- do 10-eročlani heteroaril, gdje je heterociklil ili heteroaril po izboru supstituiran halogenom;
The method of claim 36, wherein the HSV antigen is an HSV-1 antigen. The method of claim 36, wherein the HSV antigen is an HSV-2 antigen. The method of claim 34, wherein the recombinant HCMV vector comprises one or more of: (1) a point mutation in a nucleic acid sequence encoding US11, (2) a frameshift mutation in the nucleic acid sequence encoding US11, or (3) a deletion of all or part of the nucleic acid sequence encoding US11. 
Vektor CMV, namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1-5, naznačen time što vektor CMV sadrži jednu ili više točkastih mutacija u nukleinskokiselinskom slijedu koji kodira US 11, mutacija s pomakom okvira u nukleinskokiselinskom slijedu koji kodira US 11, deleciju cijelog ili dijela nukleinskokiselinskog slijeda koji kodira US11, ili protusmisleni ili RNAi konstrukt koji inhibira eksprimiranje US 11, kao što je opisano u SEQ ID NO: 4.
is an optionally substituted aryl or an optionally substituted heteroaryl; 
Yi je opcijski supstituiran aril ili opcijski supstituiran heteroaril;
Additionally, it still uses a substantially large holding tank for the water supply if large quantities of agricultural crop were to be sprayed in one session. 
Uz to, još uvijek zahtijeva značajno veliki spremnik za opskrbu vodom ako je potrebno da se u jednoj operaciji obrade velike količine poljoprivrednih usjeva.
or a therapeutically acceptable salt thereof, wherein 
. ili njegova terapeutski prihvatljiva sol pri čemu
Precipitation of the escitalopram oxalate salt: 
Datum podnošenja europske prijave patenta:
It is an object of the present invention to provide for improved, safer, more reliable telegram selection and transmission to the beacons. 
Cilj je predmetnog izuma da dade poboljšani, sigurniji, pouzdaniji odabir telegrama 1 njihovog prijenosa prema balizama.
Compounds of formula II can further be prepared by coupling of compounds of structures XVII when R″ is a hydrogen and compound XI in the presence of a suitable palladium or copper catalyst as described by Schopfer and Schlapbach Tetrahedron 2001, 57, 3069-3073; Bates et al. Org. 
Spojevi formule II nadalje se mogu pripraviti kopuliranjem spojeva struktura XVII kad je R" vodik i spoja XI uz prisutnost prikladnog paladijevog ili bakrenog katalizatora prema opisu u Schopfer i Schlapbach Tetrahedron 2001., 57, 3069-3073; Bates i sur, Org.
The method of claim 17, wherein the Gram-negative bacterium is selected from the group consisting of Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumonia. 
Spoj za uporabu prema zahtjevu 9, naznačen time da je Gram-negativna bakterija odabrana iz skupine koja se sastoji od bakterija Pseudomonas aeruginosa, Acinetobacter baumannii, i Klebsiella pneumonia.
A structure according to claim 4, characterized in that the panels of electrically welded netting are secured between the main structure (46) and the coupling plate (48) of the lateral upright (24) of the support frame (20). 
Konstrukcija u skladu s patentnim zahtjevom 2, naznačena time, da su paneli od električki zavarenih mreža pričvršćeni između glavne konstrukcije (46) i spojne ploče (48) bočnog stupića (24) potpornog okvira (20).
Example 5 Low Temperature Liquefaction of Starch or Starch Containing Materials A process according to the present invention can also be applied for low temperature processing of refined starch or starch containing materials (e.g. beet, potato, cereals from e.g. rice, wheat, rye, oat, barley, rye, sorghum). 
Postupak prema patentnom zahtjevu 1, naznačen time što je navedena biomasa koja sadrži polisaharide smjesa škroba, npr. zrna koja sadrže škrob ili rafiniranog škroba, i lignocelulozno biomase porijeklom od poljoprivrednih usjeva koji se sastoje od npr. kukuruzne stočne hrane, slame npr. od riže, pšenice, raži, ovsa, ječma, uljane repice i kineske šećerne trske, drveta koje se sastoji od mekog drveta npr. Pinus sylvestris, Pinus radiata, tvrdog drveta npr.
The method according to claim 12, wherein the material is spread by coating and/or spraying and/or dipping and/or smoothing and/or painting. 
Uporaba materijala za obradu površina sukladno bilo kojem od patentnih zahtjeva 12 do 14 je naznačena time da je taj materijal nanesen premazivanjem i/ili prskanjem i/ili potapanjem i/ili uglačavanjem i/ili bojanjem.
The composition according to any one of claims 1 to 9, wherein the mixture has a GWP of 1500 or less, and the refrigerating capacity of the mixture is 94% or more relative to the refrigerating capacity of R404A. 
Sastav prema bilo kojem od zahtjeva 1 – 5, naznačen time da mješavina ima GWP od ≤ 1500, i kapacitet hlađenja mješavine je ≥ 94% u odnosu na kapacitet hlađenja R404A.
“Alkyl” means a monovalent group derived from a saturated or unsaturated (but not aromatically unsaturated) C1–C10, preferably C1-6, hydrocarbon that may be linear, branched, or cyclic by removal of one hydrogen atom from a carbon atom, such as methyl, ethyl, propyl, 1-propenyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl, cyclopentyl, cyclopenten-1-yl, cyclopropylmethyl, cyclohexyl, and cyclohexylmethyl. 
Definicije «Alkil» znači monovalentnu skupinu izvedenu iz zasićenog ili nezasićenog (ali ne aromatskog nezasićenog) Ci.19, poželjno Cis, ugljikovodika koji može biti ravan, razgranat ili ciklički, odstranjivanjem jednog atoma vodika sa ugljikovog atoma, kao što je mtil, etil, propil, 1-propenil, izopropil, butil, izobutil, sek-butil, terc-butil, pentil, heksil, ciklopentil, ciklopenten-1-il, ciklopropilmetil, cikloheksil i cikloheksilme1l.
The electrode compartment is part of a refreshing system with a reserve container for an emulsion and a storage container for used emulsion, conduits to connect each of the containers with the electrode compartment and a transport unit, for example a pump, to move the emulsion. 
Odjeljak elektrode sukladno bilo kojem od prethodnih zahtjeva, naznačen time što je ovaj dio sustava za osvježavanje s rezervnim spremnikom za emulziju i spremnikom za skladištenje iskorištene emulzije, cijevi za spajanje svakog spremnika s odjeljkom elektrode, na primjer crpke, za pomicanje emulzije.
Release of the active ingredient was determined as follows: 
Oslobađanje djelatne tvari je određeno kako slijedi:
represents a benzene ring or a naphthalene ring; the rings being optionally substituted by 1 to 4 substituents selected from a C1-3 alkyl group, C3-5 cycloalkyl group, a C3-5 cycloalkyl-C1-4 alkyl group, a halogen atom, a C1-3 halogenated alkyl group, a hydroxyl group, a C1-3 alkoxy group optionally substituted by a C3-5 cycloalkyl group, a C1-2 perhalogenated alkoxy group, a C1-6 alkylsulfonyl group, a nitro, a cyano, an amino, a C1-3 monoalkylamino group or a C2-6 dialkylamino group; 
predstavlja benzenski prsten ili naftalenski prsten, gdje su navedeni prsteni izborno supstituirani s 1 do 4 supstituenta, koje se bira između C1-3 alkilne skupine, C3-5 cikloalkilne skupine, C3-5 cikloalkil-C1-4 alkilne skupine, atoma halogena, C1-3 halogenirane alkilne skupine, hidroksilne skupine, C1-3 alkoksi skupine, izborno supstituirane s C3-5 cikloalkilnom skupinom, C1-2 perhalogeniranom alkoksi skupinom, C1-6 alkilsulfonilnom skupina, nitro, cijano, amino, C1-3 monoalkilamino skupinom ili C2-6 dialkilamino skupinom;
Use of a compound as claimed in claim 1 or 2 in the manufacture of a medicament for the treatment or prevention of a central nervous system disorder, inflammation, pain, or neovascularization. 
Upotreba spoja prema zahtjevu 1 ili 2 u proizvodnji lijeka za liječenje ili sprječavanje poremećaja središnjeg živčanog sustava, upale, boli ili neovaskularizacije.
The video entropy decoding method of claim 1, further comprising: determining whether the dependent slice segment is includable in the picture based on first information that is obtained from a picture parameter set of the bitstream; 
jedinicu za dobivanje konfiguriranu za dobivanje, iz skupa parametara slike (PPS) trenutne slike u toku bitova, prve informacije koja pokazuje da li se ovisni segment odsječka može koristiti u trenutnoj slici;
A compound of the formula and pharmaceutically acceptable salts thereof. 
Spoj sa formulom [image] i njegove farmaceutski prihvatljive soli.
A compound for use in a method for activating pyruvate kinase R (PKR) in red blood cells in need thereof comprising contacting blood with a therapeutically effective amount of (1) a compound of formula I or a pharmaceutically acceptable salt thereof or (2) a pharmaceutically acceptable composition comprising a compound of formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, wherein: 
Spoj za uporabu u liječenju anemije srpastih stanica koji sadrži (1) spoj formule I ili njegovu farmaceutski prihvatljivu sol; ili (2) farmaceutski prihvatljivu kompoziciju koja sadrži spoj formule I ili njegovu farmaceutski prihvatljivu sol, i farmaceutski prihvatljiv nosač; pri čemu je formula I kao što je definirana u patentnom zahtjevu 1.
The apparatus according to Claim 3, wherein a center and both sides of the stirrer are open and the open portion is provided with a seal. 
Uređaj sukladno patentnom zahtjevu 1, pri čemu su središte i obje strane miješalice (32) otvoreni i otvoreni dio je u obliku brtve (36).
is hydrogen or lower alkyl optionally substituted by substituent group A 
R? je vodik ili niži alkil prema potrebi supstituiran sa supstituentskom skupinom A,